Table 4 |
|||
|
Biological tolerance to the two ACTs on days 0 and 7 |
|||
|
Day |
Artemisinine/naphtoquine |
Artemather/lumefantrine |
|
|
|
|||
|
Aneamia |
0 |
29/60 |
23/60 |
|
|
|||
|
(Hb < 11 g/d) |
48.3% |
38.3% |
|
|
|
|||
|
7 |
36/60 |
34 |
|
|
|
|||
|
60% |
56.7% |
||
|
|
|||
|
Craetinemia > 14 |
0 |
0/60 |
1/60 |
|
|
|||
|
0% |
1.7% |
||
|
|
|||
|
7 |
0/60 |
1/60 |
|
|
|
|||
|
0% |
1.7% |
||
|
|
|||
|
SGOT > 48 |
0 |
0/60 |
0/60 |
|
|
|||
|
0% |
0% |
||
|
|
|||
|
7 |
0/60 |
0/60 |
|
|
|
|||
|
0% |
0% |
||
|
|
|||
|
SGPT > 45 |
0 |
0/60 |
1/60 |
|
|
|||
|
0% |
1.7% |
||
|
|
|||
|
7 |
0/60 |
1/60 |
|
|
|
|||
|
0% |
1.7% |
||
|
|
|||
|
Toure et al. Malaria Journal 2009 8:148 doi:10.1186/1475-2875-8-148 |
|||
